Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America [Phase 4]
Phase 4 trial evaluating whether switching from COMBIGAN (brimonidine/timolol) to AZARGA (brinzolamide/timolol) improves efficacy and tolera…
-
FDA approval · 2014-04-03FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental NDA for LATANOPROST submitted by Mylan Pharmaceuticals Inc. The approval pertains to latanoprost, a therapy used…
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Relationship Between Eye Pressure and Ganglion Cell Function in Eyes Receiving Latanoprost Versus Placebo
A completed clinical trial in glaucoma comparing latanoprost to placebo and examining how changes in eye pressure relate to ganglion cell fu…
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: The Impact of a Brief Educational Intervention on Glaucoma Adherence [NA]
This entry reports on a completed clinical trial evaluating whether a brief educational intervention improves adherence to glaucoma medicati…
-
CLINICAL_TRIALS research · 2014-03-17Clinical Trial Update: The Ghana Primary Tube Versus Trabeculectomy Study [NA]
Clinical trial update comparing Ghana Primary Tube with trabeculectomy for glaucoma. No results are disclosed yet.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-03-13Clinical Trial Update: Incidence and Progression of Glaucoma in the Tema Eye Survey Cohort
This clinical trial update investigates the incidence and progression of glaucoma in the Tema Eye Survey cohort. It aims to characterize how…
-
FDA approval · 2014-03-12FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Alphagan P (brimonidine tartrate) from Allergan, indicating a modification or addition to th…
-
FDA approval · 2014-02-28FDA Approved: PHOSPHOLINE IODIDE — Supplemental Application (Fera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Phospholine Iodide (echothiophate iodide ophthalmic solution) by Fera Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2014-01-31Clinical Trial Update: Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome [Phase 2, Phase 3]
This report presents results from Phase 2/3 trials evaluating adjunctive intraoperative bevacizumab injections during trabeculectomy for gla…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Cataract Surgery vs Cataract Surgery With ECPL for Treatment of Plateau Iris Configuration or Syndrome [NA]
A completed clinical trial comparing cataract surgery alone to cataract surgery with ECPL for treatment of plateau iris configuration or syn…
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients [Phase 1]
This Phase 1 study evaluated the safety and tolerability of MRZ-99030 Eye Drops in healthy volunteers and glaucoma patients. The study statu…
-
FDA approval · 2014-01-27FDA Approved: PILOCARPINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for pilocarpine hydrochloride (Sandoz Inc) to update its labeling with additional indications.
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: Aqueous Suppressant Versus Aqueous Outflow on Ocular Blood Flow
A completed clinical trial compared aqueous suppressant versus aqueous outflow on ocular blood flow in glaucoma, with results posted in Janu…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective Data
This update reports new long-term prospective data on ocular perfusion pressure and blood flow in glaucoma patients treated with Trusopt or …
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Evaluation of OCT Measurements
The trial evaluated optical coherence tomography (OCT) measurements in patients with glaucoma or retinal diseases and has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Uptake of Comprehensive Eye Examination Trial [NA]
A Sun Yat-sen University-sponsored trial evaluating the uptake of comprehensive eye examinations for glaucoma and diabetic retinopathy has c…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Partnership for Glaucoma [NA]
A Duke University–sponsored glaucoma trial has completed as part of the Partnership for Glaucoma. The study status is listed as COMPLETED.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Analysis of Visual Pathways in Glaucoma Patients Using a 3tesla-MRI
The completed trial analyzed visual pathway integrity in glaucoma patients using 3 Tesla MRI. It examined diffusion metrics such as fraction…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Neurovascular Coupling in Eyes of Glaucoma Patients
This clinical trial update reports the completion of a study on neurovascular coupling in the eyes of glaucoma patients, including individua…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension [Phase 4]
Phase 4 trial assessing safety and efficacy of ALPHAGAN P and LUMIGAN in patients previously treated with latanoprost for glaucoma and ocula…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Ocular Hypertension Treatment Study (OHTS)
Clinical trial update indicating the Ocular Hypertension Treatment Study (OHTS) has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil [Phase 4]
A Phase 4 trial evaluating AZARGA (brinzolamide 1%/timolol 0.5%) as a replacement therapy for COMBIGAN in glaucoma patients was terminated i…
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution [Phase 2]
A Phase 2 trial comparing three formulations of AGN-210669 ophthalmic solution against Bimatoprost ophthalmic solution for glaucoma (open-an…
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: Response to SLT vs. ALT in Patients Under 60 Years of Age [NA]
This is a completed clinical trial comparing selective laser trabeculoplasty (SLT) to argon laser trabeculoplasty (ALT) for glaucoma in pati…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
This document reports the completion of a Phase 2 dose-evaluation study of the latanoprost punctal plug delivery system (L-PPDS) in subjects…